For older people and frail people, the long-term benefit of medicines reduces and the potential for harm from adverse effects increases. When the benefit–risk balance changes in this way, medicine review and optimisation are important to simplify the therapeutic regimen, reduce inappropriate medicines and minimise risks. In this article, pharmacist prescriber Linda Bryant uses two case studies to illustrate important considerations during medicine reviews
Racism and the journal - The outrage, the crossed wires, the explanations
Racism and the journal - The outrage, the crossed wires, the explanations

We are on our summer break and the editorial office is closed until 18 January. In the meantime, please enjoy our Summer Hiatus series, in which our journalists curate an eclectic mix from our news and clinical archives throughout the year, The Conversation and other publications we share content with. Please note the comment function has been turned off while we are away.
From Alan Perrott: This felt like an important story in a year full of them. It's time to climb aboard the bus of change.
Kia ora and welcome to New Zealand Doctor Rata Aotearoa
Not a subscriber? Unlock this article by subscribing here.
Selak V, Rahiri J-L, Jackson R et al. Acknowledging and acting on racism in the health sector in Aotearoa New Zealand. NZ Med J 2020;133,1521:7–13.